Maria Gasior

2.5k total citations
25 papers, 1.1k citations indexed

About

Maria Gasior is a scholar working on Psychiatry and Mental health, Clinical Psychology and Cognitive Neuroscience. According to data from OpenAlex, Maria Gasior has authored 25 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Psychiatry and Mental health, 12 papers in Clinical Psychology and 6 papers in Cognitive Neuroscience. Recurrent topics in Maria Gasior's work include Attention Deficit Hyperactivity Disorder (12 papers), Eating Disorders and Behaviors (10 papers) and Obsessive-Compulsive Spectrum Disorders (10 papers). Maria Gasior is often cited by papers focused on Attention Deficit Hyperactivity Disorder (12 papers), Eating Disorders and Behaviors (10 papers) and Obsessive-Compulsive Spectrum Disorders (10 papers). Maria Gasior collaborates with scholars based in United States, United Kingdom and France. Maria Gasior's co-authors include M. Celeste Ferreira‐Cornwell, Susan L. McElroy, James I. Hudson, Jana Radewonuk, Timothy Whitaker, Joseph Gao, Liza Squires, Matthew Brams, Denise E. Wilfley and Ann Childress and has published in prestigious journals such as Journal of the American Academy of Child & Adolescent Psychiatry, Annals of the Rheumatic Diseases and Neuropsychopharmacology.

In The Last Decade

Maria Gasior

25 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maria Gasior United States 17 567 506 206 122 103 25 1.1k
Luca Lavagnino United States 17 567 1.0× 250 0.5× 243 1.2× 38 0.3× 125 1.2× 28 936
Elizabeth P. Sparrow United States 9 225 0.4× 583 1.2× 343 1.7× 63 0.5× 65 0.6× 11 1.0k
Nicole Mori United States 22 668 1.2× 388 0.8× 64 0.3× 122 1.0× 166 1.6× 40 1.1k
Vanessa Sánchez‐Gistau Spain 21 343 0.6× 713 1.4× 187 0.9× 52 0.4× 67 0.7× 69 947
Markus Huber Italy 13 397 0.7× 426 0.8× 172 0.8× 50 0.4× 35 0.3× 30 882
D R Sweeney Australia 12 533 0.9× 250 0.5× 320 1.6× 42 0.3× 56 0.5× 15 860
G Ratzoni Israel 12 544 1.0× 469 0.9× 331 1.6× 32 0.3× 33 0.3× 17 925
Agnieszka Słopień Poland 15 315 0.6× 210 0.4× 107 0.5× 16 0.1× 121 1.2× 76 678
Timothy E. Wilens United States 16 342 0.6× 912 1.8× 385 1.9× 89 0.7× 115 1.1× 30 1.2k
Małgorzata Janas–Kozik Poland 15 348 0.6× 159 0.3× 132 0.6× 20 0.2× 107 1.0× 83 679

Countries citing papers authored by Maria Gasior

Since Specialization
Citations

This map shows the geographic impact of Maria Gasior's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Gasior with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Gasior more than expected).

Fields of papers citing papers by Maria Gasior

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Gasior. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Gasior. The network helps show where Maria Gasior may publish in the future.

Co-authorship network of co-authors of Maria Gasior

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Gasior. A scholar is included among the top collaborators of Maria Gasior based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Gasior. Maria Gasior is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Denton, Christopher P., Otylia Kowal‐Bielecka, Marzena Olesińska, et al.. (2023). POS1278 SAFETY AND PHARMACOKINETICS OF IGPRO20 (SUBCUTANEOUS IMMUNOGLOBULIN) AND IGPRO10 (INTRAVENOUS IMMUNOGLOBULIN) IN ADULTS WITH SYSTEMIC SCLEROSIS (SSC) – RESULTS FROM A PHASE 2 TRIAL. Annals of the Rheumatic Diseases. 82. 985–985. 3 indexed citations
2.
3.
McElroy, Susan L., James I. Hudson, Maria Gasior, et al.. (2017). Time course of the effects of lisdexamfetamine dimesylate in two phase 3, randomized, double‐blind, placebo‐controlled trials in adults with binge‐eating disorder. International Journal of Eating Disorders. 50(8). 884–892. 17 indexed citations
4.
Gasior, Maria, James I. Hudson, Javier Quintero, et al.. (2017). A Phase 3, Multicenter, Open-Label, 12-Month Extension Safety and Tolerability Trial of Lisdexamfetamine Dimesylate in Adults With Binge Eating Disorder. Journal of Clinical Psychopharmacology. 37(3). 315–322. 37 indexed citations
5.
Pawaskar, Manjiri, Tamás Ágh, Jana Radewonuk, et al.. (2015). Longitudinal Modeling Of The Relationship Between Lisdexamfetamine Dimesylate And Health-Related Quality Of Life In Adults With Moderate To Severe Binge Eating Disorder. Value in Health. 18(7). A407–A407. 1 indexed citations
6.
McElroy, Susan L., James I. Hudson, M. Celeste Ferreira‐Cornwell, et al.. (2015). Lisdexamfetamine Dimesylate for Adults with Moderate to Severe Binge Eating Disorder: Results of Two Pivotal Phase 3 Randomized Controlled Trials. Neuropsychopharmacology. 41(5). 1251–1260. 132 indexed citations
7.
Deal, Linda S., R. Wirth, Maria Gasior, Barry K. Herman, & Susan L. McElroy. (2015). Validation of the yale‐brown obsessive compulsive scale modified for binge eating. International Journal of Eating Disorders. 48(7). 994–1004. 31 indexed citations
8.
Pawaskar, Manjiri, Zoltán Vokó, Tamás Ágh, et al.. (2015). Longitudinal Modeling The Effect Of Lisdexamfetamine Dimesylate And Changes In Binge Eating Frequency On Disability In Patients With Binge Eating Disorder. Value in Health. 18(7). A407–A407. 1 indexed citations
9.
McElroy, Susan L., James E. Mitchell, Denise E. Wilfley, et al.. (2015). Lisdexamfetamine Dimesylate Effects on Binge Eating Behaviour and Obsessive–Compulsive and Impulsive Features in Adults with Binge Eating Disorder. European Eating Disorders Review. 24(3). 223–231. 58 indexed citations
10.
Childress, Ann, Andrew J. Cutler, Keith E. Saylor, et al.. (2014). Participant-Perceived Quality of Life in a Long-Term, Open-Label Trial of Lisdexamfetamine Dimesylate in Adolescents with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. 24(4). 210–217. 4 indexed citations
11.
Gasior, Maria, Jon Freeman, Gary Zammit, et al.. (2014). Maintenance of Wakefulness With Lisdexamfetamine Dimesylate, Compared With Placebo and Armodafinil in Healthy Adult Males Undergoing Acute Sleep Loss. Journal of Clinical Psychopharmacology. 34(6). 690–696. 4 indexed citations
12.
Coghill, David, Tobias Banaschewski, Michel Lecendreux, et al.. (2014). Maintenance of Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: Randomized-Withdrawal Study Design. Journal of the American Academy of Child & Adolescent Psychiatry. 53(6). 647–657.e1. 42 indexed citations
13.
Coghill, David, Tobias Banaschewski, Michel Lecendreux, et al.. (2013). The first European studies of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder. European Child & Adolescent Psychiatry. 22. 1 indexed citations
14.
Findling, Robert L., Andrew J. Cutler, Keith E. Saylor, et al.. (2013). A Long-Term Open-Label Safety and Effectiveness Trial of Lisdexamfetamine Dimesylate in Adolescents With Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. 23(1). 11–21. 33 indexed citations
15.
Brams, Matthew, Richard H. Weisler, Robert L. Findling, et al.. (2012). Maintenance of Efficacy of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder. The Journal of Clinical Psychiatry. 73(7). 977–983. 37 indexed citations
16.
Wigal, Timothy, et al.. (2011). Effect Size of Lisdexamfetamine Dimesylate in Adults with Attention-Deficit/Hyperactivity Disorder. Postgraduate Medicine. 123(2). 169–176. 16 indexed citations
17.
Findling, Robert L., Ann Childress, Andrew J. Cutler, et al.. (2011). Efficacy and Safety of Lisdexamfetamine Dimesylate in Adolescents With Attention-Deficit/Hyperactivity Disorder. Journal of the American Academy of Child & Adolescent Psychiatry. 50(4). 395–405. 101 indexed citations
18.
Brams, Matthew, et al.. (2011). Effects of Open-Label Lisdexamfetamine Dimesylate on Self-Reported Quality of Life in Adults with ADHD. Postgraduate Medicine. 123(3). 99–108. 13 indexed citations
19.
20.
Berlin, Ivan, Maria Gasior, & Eric T. Moolchan. (2007). Sex-based and hormonal contraception effects on the metabolism of nicotine among adolescent tobacco-dependent smokers. Nicotine & Tobacco Research. 9(4). 493–498. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luca Lavagnino Breakdown of academic impact, for papers by Elizabeth P. Sparrow Breakdown of academic impact, for papers by Nicole Mori Breakdown of academic impact, for papers by Vanessa Sánchez‐Gistau Breakdown of academic impact, for papers by Markus Huber Breakdown of academic impact, for papers by D R Sweeney Breakdown of academic impact, for papers by G Ratzoni Breakdown of academic impact, for papers by Agnieszka Słopień Breakdown of academic impact, for papers by Timothy E. Wilens Breakdown of academic impact, for papers by Małgorzata Janas–Kozik
Rankless by CCL
2026